GENEVA, Dec. 29 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2024/055936) for "NUCLEIC ACID LIGATION METHOD" on Jun 18, 2024. With publication no. WO/2025/262452, the details related to the patent application was published on Dec 26, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MANN, Gregory (Novartis Pharma AGLichtstrasse 354056 Basel)
Abstract: The present disclosure relates to biocatalytic ligation methods for producing an injectable formulation comprising an oligonucleotide; to biocatalytic ligation methods for producing sterile oligonucleotides; and t...